Raising growth-stage capital in healthtech.
Growth rounds fund health care leaders on the way to an exit. Investors read you like a public company: steady contracts, strong compliance and a clear path to profit.
Healthtech
Healthtech investors look past the demo to three questions: who pays, what evidence proves it works, and whether you can handle patient data safely. Long sales cycles shape every round.
What growth investors expect in healthtech
Growth investors compare you with listed health care companies. Be ready for that lens.
Predictable contracted revenue
- Multi-year contracts with high renewal
- No single payer or health system dominating revenue
- Forecasts you have hit before
A path to profit
- Profitable customer segments today
- Operating leverage as clinical work is automated
- A plan with dates, not hopes
Exit-grade compliance
- Audited accounts and strong governance
- Clean privacy, security and billing audits
- A credible route to listing or sale
How the round comes together
Growth healthtech rounds come from growth funds, crossover investors and health care private equity.
- 1 · A growth fund leads
- 2 · Insiders and families
- 3 · Strategics
Multi-stage VCs
Often leads
Growth arms of large funds lead many late healthtech rounds.
Corporate VCs
Sometimes
Payers and health systems invest ahead of a possible acquisition.
Family offices
Often follows
Large families write sizeable late-stage checks.
Angels
Now and then
Individuals rarely take part, except through secondary sales.
Structure decides the outcome
Growth rounds can include structured terms: higher preferences, ratchets or protections tied to an exit. A clean, simple round is often worth a lower headline valuation.
The slides investors read first
Scale
Revenue, lives covered and customers today.
Profit
Where you make money, and when overall.
Compliance
Privacy, security and billing audit record.
Market
Your position against listed health peers.
Exit
Timeline and the route you expect.
Questions founders ask
What is a crossover investor?
A fund that invests in both private and public companies. They often join the last private round before a listing.
Will a strategic investor block a sale to a competitor?
Some ask for rights that can slow a sale, such as a right of first refusal. Read those terms closely and get your lawyer to explain what they allow.
Sources
Sources: HHS guidance on HIPAA; FDA guidance on digital health software; CMS reimbursement resources; investors' published criteria. Editorial content, reviewed quarterly. Not financial, legal or medical advice.
Other stages
Related sectors
Who funds this round
Learn the terms
Run the numbers
Raise in your city
Inside Unicorn Factory
Free account
Investor matching is coming to your free account. Create it now and we will match your round the day it opens. Until then, get an honest read on your deck.